See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2023_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 374,727,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 104,179,000 |
| 2 | PropertyPlantAndEquipmentNet | 22,139,000 |
| 3 | remainder_Assets | 80,855,000 |
| 4 | LiabilitiesCurrent | 75,682,000 |
| 5 | LiabilitiesNoncurrent | 114,244,000 |
| 6 | remainder_Liabilities | 379,374,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 257,774,240 |
| 9 | ResearchAndDevelopmentExpense | 91,254,635 |
| 10 | remainder_Expenses | 778,417,200 |
| 11 | remainder_Revenues | 404,924,349 |
| 12 | remainder_NetIncome | 2,229,773 |
| 13 | remainder_ComprehensiveNetIncome | -436,013 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 581,900,000 |
| 1 | Liabilities | 569,300,000 |
| 2 | Expenses | 1,127,446,075 |
| 3 | Revenues | 404,924,349 |
| 4 | StockholdersEquity | 12,600,000 |
| 5 | NetIncome | -720,291,953 |
| 6 | ComprehensiveNetIncome | -720,509,960 |
| 7 | BaseVar | 1,343,118,105 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.20 |
| 9 | EconomicCapitalRatio | 1.26 |
Edgar->Model Mapping
Feature Distribution
Change over Time
